Related Experiment Video
Updated: Oct 14, 2025

Vinyl Chloride and High-Fat Diet as a Model of Environment and Obesity Interaction
Published on: January 12, 2020
Alcohol and Metabolic-associated Fatty Liver Disease
1Department of Elderly Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
This review examines how alcohol consumption, particularly light to moderate intake, impacts metabolic-associated fatty liver disease (MAFLD) and related metabolic functions like obesity and blood pressure. Findings on alcohol
Area of Science:
- Hepatology
- Metabolic Disorders
- Nutritional Science
Background:
- Metabolic-associated fatty liver disease (MAFLD) diagnosis relies on liver steatosis and metabolic dysfunction.
- MAFLD diagnosis is now independent of alcohol consumption levels.
- Alcohol metabolism influences metabolic abnormalities, with varied effects observed.
Purpose of the Study:
- To systematically review the effects of alcohol consumption on metabolic dysfunction.
- To focus on light to moderate alcohol intake in relation to MAFLD.
- To analyze alcohol's impact on obesity, lipid and glucose metabolism, and blood pressure.
Main Methods:
- Systematic literature review.
- Analysis of studies investigating alcohol intake and metabolic parameters.
- Synthesis of diverse and often controversial findings.
Main Results:
- Light to moderate alcohol consumption has shown potential for improved metabolic function in some studies.
- However, research findings are diverse and conclusions are frequently debated.
- The precise role of alcohol in metabolic dysfunction remains complex.
Conclusions:
- Further research is needed to clarify the controversial relationship between alcohol intake and MAFLD.
- Understanding these interactions is crucial for managing metabolic health.
- The review highlights the need for nuanced interpretation of alcohol's metabolic effects.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Aldehydes and Ketones with Alcohols: Hemiacetal Formation

